Haleon plc
Haleon plc is a consumer healthcare company with no direct federal contracts, lobbying, or corporate insider buys, but faces low-impact legislative exposure from eight healthcare bills.
BusinessWhat HLN does
Haleon plc is a global consumer healthcare company formed from the demerger of GSK's consumer health division, generating revenue from over-the-counter (OTC) medicines, vitamins, minerals, and supplements (VMS), and oral health products. Its business model relies on brand recognition and retail distribution for products like Advil, Centrum, and Sensodyne. Revenue is derived from direct sales to retailers and distributors worldwide.
12 months past · 3 months futureHLN activity timeline
Lifetime Government AwardsHLN federal contracts
HLN doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HLN
Politicians Trading HLNMembers of Congress with recent HLN positions
Congressional TradesWho in Congress is trading HLN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting HLNLive legislation impacting this stock
Political ProfileWhere HLN sits in Washington
[object Object]
STRUCTURAL: High regulatory density score (85) due to healthcare sector exposure to eight low-impact bills. EVIDENTIARY: No federal contracts (`get_government_precedent.federal_contracts_summary` is null), zero lobbying spend (`get_political_influence.lobbying.total_income` is 0), zero corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys` is 0), and only four congressional trade transactions (two sales, one purchase, one duplicate) across two members. Net: Minimal direct political engagement against a backdrop of sector-wide regulatory risk.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad legislative exposure to healthcare regulationU.S. Congress"Eight recent bills in `Recent bill_impacts` all show impact_ratio 0.0001 on the healthcare sector."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Live signals + predictions for HLN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HLN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord